Chapter
First Omicron-Targeted Vaccine Approved by FDA
39:45 - 41:51 (02:06)
The FDA has granted emergency use authorization to a new formulation of the COVID-19 vaccine specifically targeting the Omicron variant. Booster shots will be available next week and infections and deaths continue to be recorded in high numbers in the US.
Clips
The FDA has authorized a new formulation of the coronavirus vaccine to target the Omicron variant.
39:45 - 41:51 (02:06)
FDA, coronavirus
Summary
The FDA has authorized a new formulation of the coronavirus vaccine to target the Omicron variant. Booster shots of the new vaccine will be available next week amidst continued high levels of infections and deaths in the United States.